SKLB610
mRNA synthesis
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
Tyramide Signal Amplification (TSA)
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Phos Binding Reagent Acrylamide
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
Cell Counting Kit-8 (CCK-8)
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
SYBR Safe DNA Gel Stain
Safe and sensitive stain for visualization of DNA or RNA in agarose or acrylamide gels.
Inhibitor Cocktails
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
SKLB610是VEGFR的选择性抑制剂,IC50值为2.2 μM[1]。
VEGFR(血管内皮生长因子受体)的配体是VEGF,通过与VEGF结合,在刺激细胞应答中发挥重要作用。研究表明,在多种癌症中,VEGFR异常表达,其抑制剂被视为有前景的临床治疗方式[1,2]。
SKLB610是VEGF诱导的VEGFR2磷酸化的强效抑制剂。在人肿瘤细胞系中,SKLB610抑制细胞增殖,IC50值为2.2 μM 到25.6 μM。在HUVECs中,SKLB610抑制VEGF刺激的细胞增殖以及VEGFR2磷酸化,以剂量依赖性方式抑制细胞毛细血管形成[1]。SKLB610在水、乙醇、乙酸乙酯、0.5%的Tween 80和纳米混悬剂的溶解度分别为0.34 μg/ml、16500 μg/ml、380 μg/ml、23 μg/ml和103 μg/ml [2,3]。
在HCT116皮下异种移植小鼠模型中,剂量为12.5 mg/kg、25 mg/kg 和 50 mg/kg 的SKLB610治疗10天,浓度依赖性的显著延迟肿瘤生长。另外,经过30天的治疗,50 mg/kg剂量的SKLB610抑制77.1%的肿瘤体积 [1]。
参考文献:
[1]. Cao, Z.X., et al., SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo. Cell Physiol Biochem, 2011. 27(5): p. 565-74.
[2]. Luo, X., et al., Pharmacokinetic studies of a novel multikinase inhibitor for treating cancer by HPLC-UV. J Chromatogr Sci, 2013. 51(1): p. 17-20.
[3]. Huang, Y., et al., The preparation and evaluation of water-soluble SKLB610 nanosuspensions with improved bioavailability. AAPS PharmSciTech, 2013. 14(3): p. 1236-43.
Physical Appearance | A solid |
Storage | Store at 4°C |
M.Wt | 415.11 |
Cas No. | 1125780-41-7 |
Formula | C21H16F3N3O3 |
Synonyms | SKLB610; SKLB 610; SKLB-610 |
Solubility | insoluble in H2O; ≥20.75 mg/mL in DMSO; ≥23 mg/mL in EtOH with ultrasonic |
Chemical Name | N-methyl-4-(4-(3-(trifluoromethyl)benzamido)phenoxy)picolinamide |
SDF | Download SDF |
Canonical SMILES | FC(F)(F)C1=CC=CC(C(NC2=CC=C(OC3=CC=NC(C(NC)=O)=C3)C=C2)=O)=C1 |
运输条件 | 蓝冰运输或根据您的需求运输。 |
一般建议 | 不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。 |
Description | SKLB610是血管发生相关的酪氨酸激酶的新型多靶点抑制剂。 | |||||
靶点 | FGFR | |||||
IC50 |
质量控制和MSDS
- 批次: